Unum Therapeutics Inc (NASDAQ:UMRX)

0.965
Delayed Data
As of Jan 16
 +0.035 / +3.76%
Today’s Change
0.48
Today|||52-Week Range
4.94
+33.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
AssetsCash90.5M41.3M28.3M55.7M
 
 
 
 
 
Short Term Investment Cash86.5M-49.2M-13.0M27.3M
 
 
 
 
 
Cash & Short Term Investments90.5M68.5M41.0M78.6M
 
 
 
 
 
 
ReceivablesReceivables294.0K928.0K830.0K1.7M
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets326.0K296.0K513.0K740.0K
 
 
 
 
 
Current Assets91.1M69.7M42.4M81.0M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.6M5.6M6.3M6.7M
 
 
 
 
 
Depreciation-179.0K-1.0M-2.2M-3.5M
 
 
 
 
 
Other Assets0.000.001.4M419.0K
 
 
 
Total Assets94.8M75.6M49.1M85.9M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.4M1.5M1.3M1.5M
 
 
 
 
 
Accrued Expenses50.0K118.0K1.6M3.9M
 
 
 
 
 
Other Current Liabilities5.3M6.1M8.5M21.8M
 
 
 
 
 
Other Liabilities7.3M8.7M11.2M24.9M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities665.0K908.0K906.0K748.0K
 
 
 
 
 
Total Liabilities25.3M23.2M20.8M25.7M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock77.0M77.1M77.2M0.00
 
 
 
 
Common Equity-7.5M-24.7M-48.8M60.2M
 
 
 
 
 
Total Shareholder Equity69.5M52.4M28.3M60.2M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding16.0M30.5M30.5M30.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.